|
| Tuesday, May 5, 2015 |
|
|
What Role Will Institutional Investors Play in Building a Financial Sector that Serves the Real Economy? |
| Interviews with Mohamed El-Erian and Eloy Lindeijer, speakers at the marcus evans European Pensions & Investments Summit 2015, taking place in Montreux, Switzerland, 8 - 10 June, 2015. more info >> |
|
|
Clinical Documentation Improvement Will Drive Hospital Revenue |
| "Clinical Documentation Improvement (CDI) has become critical to hospital performance, not just for financial reasons, but for making sure they are able to capture quality outcomes with value-based purchasing," says Joanne Webb, SVP Healthcare, J.A. Thomas & Associates, a Nuance company. more info >> |
|
| Friday, May 1, 2015 |
|
|
The Property Investment Opportunities to Look At in The Netherlands |
| "There is a huge market gap for professionally managed elderly rental properties in The Netherlands," according to Bart Hostens, Managing Director, Belfort Fund Management BV. more info >> |
|
|
Conducting Clinical Trials in Emerging Markets with a CRO Alliance |
| "Statistics show that more than 80 percent of pharma and biotech companies are willing to conduct clinical trials in emerging markets, however a number of them are unable to identify good quality contract research organizations (CROs) to work with in different countries," says Natalia Fetkovska, MD, PhD, Senior Partner, SanaClis s.r.o. more info >> |
|
|
Clinical Trial Efficiency Should Be a Key Focus |
| "Most clinical trial management systems are geared towards a specific type of specialty, and are not platform independent or fully mobile. The next generation clinical trial tool set will need to combine existing techniques and focus more on efficiency," he adds more info >> |
|
| Wednesday, April 22, 2015 |
|
|
Why Investors Must Look at the Consumer Sector in Emerging Markets |
| "In the last 30 years, consumer sector businesses in both developed and developing markets have performed much better than those in other sectors. That is why it is the only sector we look at," according to James Alexandroff, one of the Founding Partners of Arisaig Partners. more info >> |
|
|
Why Quantitative Comparison of Patient Recruitment is a Must |
| Clinical trial patient recruitment has reached a point where finding patients from outside the practice is necessary. Adding new sites is not always possible or affordable, says Roger Smith, Senior Vice President & General Manager, Acurian. more info >> |
|
| Friday, April 17, 2015 |
|
|
What Investors Need to Know About Investing in the APAC Region |
| "The current monetary and fiscal policy in the APAC region still generally accommodates equities but investors have to be mindful of the risks, especially the changing fundamentals of different sectors, and be nimble enough to change their investment allocation," says Ismitz Matthew De Alwis, Executive Director & Chief Executive Officer, Kenanga Investors Berhad. more info >> |
|
| Wednesday, April 15, 2015 |
|
|
Transforming the Pharmacy in Long-Term Care |
| "The medication error rate in long-term care (LTC) is high and I believe, most of it undocumented. That leads to poor healthcare outcomes, unnecessary readmissions and medication waste," says Rick Rondinelli, President & Chief Executive Officer, In Touch Pharmaceuticals. more info >> |
|
|
Why Timing is Crucial in Clinical Research Recruitment |
| "Timing is crucial when finding the right candidate. Any time wasted in filling a position can delay a new drug from reaching market," according to Tim Wierenga, Chief Executive Officer, ClinLinks. more info >> |
|
|
|
